Cargando…
Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel
BACKGROUND: Mekong schistosomiasis is a parasitic disease caused by the blood-dwelling fluke Schistosoma mekongi. This disease contributes to human morbidity and mortality in the Mekong region, posing a public health threat to people in the area. Currently, praziquantel (PZQ) is the drug of choice f...
Autores principales: | Chienwichai, Peerut, Tipthara, Phornpimon, Tarning, Joel, Limpanont, Yanin, Chusongsang, Phiraphol, Chusongsang, Yupa, Adisakwattana, Poom, Reamtong, Onrapak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412319/ https://www.ncbi.nlm.nih.gov/pubmed/34473691 http://dx.doi.org/10.1371/journal.pntd.0009706 |
Ejemplares similares
-
Untargeted serum metabolomic profiling for early detection of Schistosoma mekongi infection in mouse model
por: Chienwichai, Peerut, et al.
Publicado: (2022) -
Effect of Praziquantel on Schistosoma mekongi Proteome and Phosphoproteome
por: Chienwichai, Peerut, et al.
Publicado: (2020) -
Discovery of Schistosoma mekongi circulating proteins and antigens in infected mouse sera
por: Uthailak, Naphatsamon, et al.
Publicado: (2022) -
Identification of Low Molecular Weight Proteins and Peptides from Schistosoma mekongi Worm, Egg and Infected Mouse Sera
por: Thiangtrongjit, Tipparat, et al.
Publicado: (2021) -
Phosphoproteomics analysis of male and female Schistosoma mekongi adult worms
por: Simanon, Nattapon, et al.
Publicado: (2019)